• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶(LDH)水平升高作为新型冠状病毒肺炎(COVID-19)严重程度和死亡率的独立危险因素。

Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.

作者信息

Li Chang, Ye Jianfang, Chen Qijian, Hu Weihua, Wang Lingling, Fan Yameng, Lu Zhanjin, Chen Jie, Chen Zaishu, Chen Shiyan, Tong Junlu, Xiao Wei, Mei Jin, Lu Hongyun

机构信息

Department of Cardiology, Hubei No.3 People's Hospital of Jianghan University, Wuhan 430033, Hubei Province, China.

Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.

出版信息

Aging (Albany NY). 2020 Aug 14;12(15):15670-15681. doi: 10.18632/aging.103770.

DOI:10.18632/aging.103770
PMID:32805722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7467395/
Abstract

Early identification of severe patients with coronavirus disease 2019 (COVID-19) is very important for individual treatment. We included 203 patients with COVID-19 by propensity score matching in this retrospective, case-control study. The effects of serum lactate dehydrogenase (LDH) at admission on patients with COVID-19 were evaluated. We found that serum LDH levels had a 58.7% sensitivity and 82.0% specificity, based on a best cut-off of 277.00 U/L, for predicting severe COVID-19. And a cut-off of 359.50 U/L of the serum LDH levels resulted in a 93.8% sensitivity, 88.2% specificity for predicting death of COVID-19. Additionally, logistic regression analysis and Cox proportional hazards model respectively indicated that elevated LDH level was an independent risk factor for the severity (HR: 2.73, 95% CI: 1.25-5.97; P=0.012) and mortality (HR: 40.50, 95% CI: 3.65-449.28; P=0.003) of COVID-19. Therefore, elevated LDH level at admission is an independent risk factor for the severity and mortality of COVID-19. LDH can assist in the early evaluating of COVID-19. Clinicians should pay attention to the serum LDH level at admission for patients with COVID-19.

摘要

早期识别新型冠状病毒肺炎(COVID-19)重症患者对于个体治疗非常重要。在这项回顾性病例对照研究中,我们通过倾向评分匹配纳入了203例COVID-19患者。评估了入院时血清乳酸脱氢酶(LDH)对COVID-19患者的影响。我们发现,基于277.00 U/L的最佳截断值,血清LDH水平预测重症COVID-19的敏感度为58.7%,特异度为82.0%。血清LDH水平截断值为359.50 U/L时,预测COVID-19死亡的敏感度为93.8%,特异度为88.2%。此外,逻辑回归分析和Cox比例风险模型分别表明,LDH水平升高是COVID-19严重程度(HR:2.73,95%CI:1.25-5.97;P=0.012)和死亡率(HR:40.50,95%CI:3.65-449.28;P=0.003)的独立危险因素。因此,入院时LDH水平升高是COVID-19严重程度和死亡率的独立危险因素。LDH可协助早期评估COVID-19。临床医生应关注COVID-19患者入院时的血清LDH水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/e6cd0643ed72/aging-12-103770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/e028222fedc3/aging-12-103770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/f95c84f2cd36/aging-12-103770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/e6cd0643ed72/aging-12-103770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/e028222fedc3/aging-12-103770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/f95c84f2cd36/aging-12-103770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc3/7467395/e6cd0643ed72/aging-12-103770-g003.jpg

相似文献

1
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.乳酸脱氢酶(LDH)水平升高作为新型冠状病毒肺炎(COVID-19)严重程度和死亡率的独立危险因素。
Aging (Albany NY). 2020 Aug 14;12(15):15670-15681. doi: 10.18632/aging.103770.
2
Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.血清乳酸脱氢酶(LDH)在 2019 新型冠状病毒(COVID-19)肺炎中的潜在临床应用价值评估。
Respir Res. 2020 Jul 6;21(1):171. doi: 10.1186/s12931-020-01427-8.
3
Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.COVID-19 重症和危重症患者血乳酸脱氢酶水平对住院患者病死率的预测价值。
Int J Med Sci. 2020 Aug 19;17(14):2225-2231. doi: 10.7150/ijms.47604. eCollection 2020.
4
[Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].[中国方案、肺炎严重程度指数及CURB-65在2019冠状病毒病风险分层及预后评估中的严重程度分类比较]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Oct 12;43(10):834-838. doi: 10.3760/cma.j.cn112147-20200226-00186.
5
Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.≥80 岁 COVID-19 患者的临床特征和预后因素。
Geriatr Gerontol Int. 2020 Jul;20(7):704-708. doi: 10.1111/ggi.13960. Epub 2020 Jun 9.
6
Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.血清乳酸脱氢酶与性别相结合可预测COVID-19患者的重症疾病。
Medicine (Baltimore). 2020 Oct 16;99(42):e22774. doi: 10.1097/MD.0000000000022774.
7
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.COVID-19 大流行中的一个新参数:初始乳酸脱氢酶(LDH)/淋巴细胞比值用于诊断和死亡率预测。
J Infect Public Health. 2020 Nov;13(11):1664-1670. doi: 10.1016/j.jiph.2020.09.009. Epub 2020 Sep 30.
8
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.中国武汉 COVID-19 患者炎症参数的纵向变化及其与疾病严重程度和结局的相关性。
Crit Care. 2020 Aug 27;24(1):525. doi: 10.1186/s13054-020-03255-0.
9
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.乳酸脱氢酶和 C 反应蛋白可预测 COVID-19 患者的呼吸衰竭。
Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9.
10
CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.CURB-65 可能是中国武汉 COVID-19 患者有用的预后标志物:一项回顾性队列研究。
Epidemiol Infect. 2020 Oct 1;148:e241. doi: 10.1017/S0950268820002368.

引用本文的文献

1
Profiling short-term longitudinal severity progression and associated genes in COVID-19 patients using EHR and single-cell analysis.利用电子健康记录和单细胞分析对新冠病毒患者的短期纵向严重程度进展及相关基因进行分析。
Sci Rep. 2025 Jul 1;15(1):21098. doi: 10.1038/s41598-025-07793-x.
2
Hemolysis and Its Clinical Implications in Septic Patients with Acute Respiratory Failure.脓毒症合并急性呼吸衰竭患者的溶血及其临床意义
J Clin Med. 2025 May 16;14(10):3493. doi: 10.3390/jcm14103493.
3
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
2
CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city.根据临床表现的 SARS-CoV-2 肺炎的 CT 特征:对武汉市 120 例连续患者的回顾性分析。
Eur Radiol. 2020 Aug;30(8):4417-4426. doi: 10.1007/s00330-020-06854-1. Epub 2020 Apr 11.
3
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.
新冠病毒肺炎中的炎症生物标志物与不良结局:未来病毒性大流行的前奏
J Family Med Prim Care. 2025 Feb;14(2):720-728. doi: 10.4103/jfmpc.jfmpc_1326_24. Epub 2025 Feb 21.
4
Serum Lactate Dehydrogenase Levels Reflect the Lung Injury Extension in COVID-19 Patients at Hospital Admission.血清乳酸脱氢酶水平反映新冠病毒肺炎患者入院时肺损伤的程度。
Immun Inflamm Dis. 2025 Mar;13(3):e70168. doi: 10.1002/iid3.70168.
5
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.住院患者中发生重症 COVID-19 的预测因素:一项回顾性研究。
Front Med (Lausanne). 2025 Jan 14;11:1494302. doi: 10.3389/fmed.2024.1494302. eCollection 2024.
6
Lactate dehydrogenase to albumin ratio (LAR) is a novel predictor of fatal outcome in patients with SFTS: an observational study.乳酸脱氢酶与白蛋白比值(LAR)是严重发热伴血小板减少综合征患者死亡结局的新型预测指标:一项观察性研究。
Front Public Health. 2024 Dec 17;12:1459712. doi: 10.3389/fpubh.2024.1459712. eCollection 2024.
7
Carnosic acid prevents heat stress-induced oxidative damage by regulating heat-shock proteins and apoptotic proteins in mouse testis.肌醇六磷酸通过调节小鼠睾丸中的热休克蛋白和凋亡蛋白来预防热应激诱导的氧化损伤。
Biol Chem. 2024 Dec 6;405(11-12):745-749. doi: 10.1515/hsz-2023-0374. Print 2024 Dec 17.
8
Predictive factors associated with short-term mortality in cats with feline infectious peritonitis treated with remdesivir or GS-441524 or both.接受瑞德西韦或GS-441524或两者治疗的猫传染性腹膜炎猫短期死亡率的相关预测因素。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17249. doi: 10.1111/jvim.17249. Epub 2024 Nov 27.
9
Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms.血浆线粒体和核 DNA 碎裂组学为重症 COVID-19 患者的预后提供信息。
BMC Med Genomics. 2024 Oct 4;17(1):243. doi: 10.1186/s12920-024-02022-2.
10
Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report.HIV/利什曼原虫合并感染严重 COVID-19 患者:成功管理的病例报告。
BMC Infect Dis. 2024 Aug 23;24(1):854. doi: 10.1186/s12879-024-09691-5.
不同严重程度的 COVID-19:一项多中心临床特征研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.
4
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.预测 SARS-CoV-2 引起的 COVID-19 肺炎患者死亡率的前瞻性队列研究。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.00524-2020. Print 2020 May.
5
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病(COVID-19)进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
6
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响:一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
7
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
8
[Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7) "].[《国家卫生健康委新冠肺炎诊疗方案(试行第七版)》病理改变解读]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):397-399. doi: 10.3760/cma.j.cn112151-20200318-00221.
9
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China.中国武汉2019年新型冠状病毒肺炎难治性病例的临床特征
Clin Infect Dis. 2021 Dec 6;73(11):e4208-e4213. doi: 10.1093/cid/ciaa270.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.